Trial Profile
The Efficacy and Feasibility Study of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer (Est-Neo)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cetuximab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 29 May 2012 Additional trial centres identified as reported by University Hospital Medical Information Network - Japan.
- 16 Nov 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2011 New trial record